Log In
Print this Print this

MUC1 naked DNA cancer vaccine

  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionNon-viral DNA based vaccine against the MUC1 tumor antigen
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsVaccinate against cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today